Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Yatin Mundkur
AddedMar 31, 2024
UpdatedMay 31, 2026
Yatin Mundkur

Yatin Mundkur

Board Member, Yantra

Crunchbase

Yatin Mundkur's Career

Yantra
Yantra

Lawrence, KS, US

Board Member· Board
Xambala
Xambala

Sunnyvale, CA, US

Board Member· Board
Cellworks
Cellworks

South San Francisco, CA, US

CEO· C-Suite · Management
Virsec Systems
Virsec Systems

San Jose, CA, US

Board Member· Board
zSpace
zSpace

Sunnyvale, CA, US

Board Member· Board
Prysm
Prysm

San Jose, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Yatin Mundkur's Career

Yantra
Yantra
Investment FirmInvestment Firm$8M1252012Lawrence, KS, US
Board Member· Board

Leadership at Yantra

Suresh RamamurthiSuresh RamamurthiCo-Founder
Devdutt YellurkarDevdutt YellurkarCo-Founder
Pramod VarmaPramod VarmaCo-Founder
Xambala
Xambala
Investment FirmInvestment Firm$92.7M132001Sunnyvale, CA, US
Board Member· Board

Leadership at Xambala

Jim SmithJim SmithBoard Member
Rajan RaghavanRajan RaghavanFounder
Cellworks
Cellworks
Series B$33M1562005South San Francisco, CA, US
CEO· C-Suite · Management

Leadership at Cellworks

Pradeep FernandesPradeep FernandesCo-Founder
Allen LichterAllen LichterBoard Member
Taher AbbasiTaher AbbasiCo-Founder
Shireen ValiShireen ValiCo-Founder

Similar to Cellworks

ExpressCellsExpressCellsPhiladelphia, PA, USCell Linesest. 2018ExpressCellsPhiladelphia, PA, US · est. 2018

ExpressCells customizes human cell lines for biological research and drug discovery using proprietary gene-editing tools.

Pre-Seed · $1.8M8
CelldomCelldomDurham, NC, USSingle-Cell Analysisest. 2016CelldomDurham, NC, US · est. 2016

Celldom advances research and drug development with high-throughput, next-gen single-cell analysis technology.

Seed · $1.9M5
Cellix BioCellix BioNewark, NJ, USMedical Researchest. 2013Cellix BioNewark, NJ, US · est. 2013

Cellix Bio: Advancing medical research for enhanced drug development and faster recovery in immune diseases.

Series A · $14.3M30
CelltheonCelltheonUnion City, CA, USBiologics, Pharmaceuticalsest. 2012CelltheonUnion City, CA, US · est. 2012

Celltheon Corp: Pioneering cell-engineering tech for human and veterinary pharmaceuticals since 2012.

Angel · $200k34
Virsec Systems
Virsec Systems
Series C$134.6M1732013San Jose, CA, US
Board Member· Board

Leadership at Virsec Systems

Dave FurneauxDave FurneauxBoard Member
Satya GuptaSatya GuptaCo-Founder
Ray DeMeoRay DeMeoCo-Founder
Simone SassoliSimone SassoliCEO
Atiq RazaAtiq RazaBoard Member
Mike RuettgersMike RuettgersBoard Member

Similar to Virsec Systems

Vir-SecVir-SecLargo, FL, USSecurity SoftwareVir-SecLargo, FL, US

Vir-Sec, Inc. offers patented virtual security software for unmatched, secure access to private data online.

Pre-Seed · $1.3M30
ThreatLockerThreatLockerOrlando, FL, USCybersecurity, Softwareest. 2017ThreatLockerOrlando, FL, US · est. 2017

ThreatLocker: A leading cybersecurity provider offering comprehensive, simple security solutions.

Series D · $188.3M327
Cequence SecurityCequence SecuritySunnyvale, CA, USAPI Security, Cybersecurityest. 2014Cequence SecuritySunnyvale, CA, US · est. 2014

Cequence Security: An AI-powered cybersecurity software firm, specializing in API and web application protection.

Late Stage Private · $101.5M184
Contrast SecurityContrast SecurityLos Altos, CA, USSecurity SoftwareContrast SecurityLos Altos, CA, US

Contrast Security, Inc. provides self-protecting software security tools against cyberattacks globally.

Series E · $269M339
zSpace
zSpace
Series A$76.6M1762007Sunnyvale, CA, US
Board Member· Board

Leadership at zSpace

Paul KellenbergerPaul KellenbergerFounder
Prysm
Prysm
Acquired$293.1M02005San Jose, CA, US
Board Member· Board

Leadership at Prysm

Kumar GBKumar GBBoard Member
Tim WilsonTim WilsonBoard Member
Roger HajjarRoger HajjarFounder
J Heidi RoizenJ Heidi RoizenBoard Member
Amit JainAmit JainCEO

Yatin Mundkur's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Yatin Mundkur

David NorrisDavid NorrisBoard Member · PreemYevgen BrightYevgen BrightCo-Founder · Group&WorkDave DalyDave DalyBoard Member · NeoGenomics LaboratoriesDrew SenyeiDrew SenyeiBoard Member · CelulaSanjeev SinghSanjeev SinghCo-Founder & CEO · ZenworkJay YuJay YuBoard Member · Test Diagnostics